MSPR/Ron Beta Antibody (Aveo anti-RON) [PE]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-28436PE
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA, Flow Cytometry, Functional
Label
PE (Excitation = 488 nm, Emission = 575 nm)
Antibody Source
Recombinant Monoclonal Human IgG1 Clone # Aveo anti-RON
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
MSPR / RON / CD136
Clonality
Monoclonal
Host
Human
Isotype
IgG1
Applications for MSPR/Ron Beta Antibody (Aveo anti-RON) [PE]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Functional
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: MSPR/Ron Beta
Alternate Names
CD136, CDw136, Macrophage-stimulating protein receptor beta chain, MSP receptor, NPCA3, p185-Ron, Protein-tyrosine kinase 8, PTK8, Ron
Gene Symbol
MST1R
Additional MSPR/Ron Beta Products
Product Documents for MSPR/Ron Beta Antibody (Aveo anti-RON) [PE]
Product Specific Notices for MSPR/Ron Beta Antibody (Aveo anti-RON) [PE]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...